Publicaciones en las que colabora con CARLA PATRICIA RÍOS LUCI (4)

2020

  1. Adaptive resistance to trastuzumab impairs response to neratinib and lapatinib through deregulation of cell death mechanisms

    Cancer Letters, Vol. 470, pp. 161-169

2019

  1. TRAIL receptor activation overcomes resistance to trastuzumab in HER2 positive breast cancer cells

    Cancer Letters, Vol. 453, pp. 34-44

2017

  1. Resistance to the antibody–drug conjugate T-DM1 is based in a reduction in lysosomal proteolytic activity

    Cancer Research, Vol. 77, Núm. 17, pp. 4639-4651

2011

  1. A modular approach to trim cellular targets in anticancer drug discovery

    Bioorganic and Medicinal Chemistry Letters, Vol. 21, Núm. 22, pp. 6641-6645